Applied DNA Sciences, Inc. (APDN) Financials

APDN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 9.9 million 5.8 million
2023-09-30 13.7 million 8.8 million
2023-06-30 15.8 million 8.6 million
2023-03-31 19.2 million 9.2 million

APDN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -3.8 million 340705
2023-09-30 -2.6 million 341495
2023-06-30 -1.5 million 340042
2023-03-31 160049 258604

APDN Net Income

No data available :(

APDN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 3.4 million - 1.1 million
2023-09-30 7.2 million - 1.2 million
2023-06-30 10.8 million - 1.4 million
2023-03-31 12.3 million - 1.5 million

APDN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 13.7 million
2023-09-30 13.1 million
2023-06-30 12.9 million
2023-03-31 12.9 million

APDN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 935815 3.1 million -
2023-09-30 117072 938907 3.3 million -
2023-06-30 161800 836123 3.3 million -
2023-03-31 54339 988744 3.5 million -

APDN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 891164 660067
2023-09-30 779736 700740
2023-06-30 2.9 million 1.6 million
2023-03-31 4.4 million 2.6 million

APDN

Price: $4.37

52 week price:
0.24
5.00

Earnings Per Share: -0.55 USD

P/E Ratio: -1.10

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 276529

Ebitda: -5.5 million

Market Capitalization: 6.4 million

Links: